Bruce J. Spohler
Analyst · JPMorgan
Thank you, Rich. Let me start by making an overall observation regarding our portfolio. Our management teams are optimistic about their respective businesses. However, they continue to be cautious regarding the economic fundamentals and ongoing macro uncertainties. The operating trends of our portfolio of companies remain stable, with steady deleveraging in an environment of muted top line growth and a continued focus on cost efficiencies. As we've highlighted before during our underwriting process, we will focus on a company's ability to generate free cash flow as the primary driver to derisk and repay our investment. The defensive portfolio that we've constructed at Solar, concentrated in noncyclical industries, continues to perform well in this low-growth environment. Now let me touch on the portfolio. At the end of Q1, the fair market value of our investment portfolio was approximately $1.4 billion, consistent with our prior quarter. All but 1 asset, Rug Doctor, which I will discuss further, is performing. At March 31, the fair value weighted average mark on our portfolio, excluding common equity, was approximately $0.97 of par, and the weighted average yield on our income-producing portfolio was 13.3%. Our income-producing assets represent approximately 94% of the total portfolio, and the weighted average investment risk rating remained at approximately 2, measured at fair market value at the end of the year based on our 1 to 4 risk rating scale, with 1 representing the least amount of risk. At March 31, our portfolio consisted of 40 companies operating across 22 industries, and was invested 36% in senior secured loans, 28% in subordinated debt, 11% in preferred equity, and 23% in common equity and warrants as measured at fair value. If we were to include Crystal's underlying portfolio of loans, 61% of our total investment exposure across the entire portfolio is in secured investments, and 50% of the portfolio is floating rate investments measured at fair value. This reflects our concerted effort to move higher in the capital structure and shorten duration risk in response to the frothy credit market environment. Solar Capital has invested approximately $3 billion across 85 portfolio companies. Over this period, we have completed transactions with more than 70 different financial sponsors. Before I give you an overview of Q1's activity, I'd like to spend a moment on a couple of portfolio developments. As Rich mentioned, subsequent to year end, we placed our investment in Rug Doctor on nonaccrual, as we had passed on during our earlier earnings call. We're in active discussions with the company, as well as the sponsor, and view our attachment point for our investment, which is in the low-3x EBITDA, as a positive factor in maximizing our realizable value. Discussions are underway and we will keep you apprised as we move forward. As of March, Crystal Financial had a highly diversified secured loan portfolio totaling approximately $411 million, consisted of 26 loans to 21 different issuers, representing a slight increase from the size of the portfolio at year-end 2012. Again, all of their loans are floating rate. The average loan size approximately $16 million, and the weighted average yield is in the mid-12s at 3/31. The Crystal portfolio is 100% performing. At the end of the quarter, total debt on the Crystal portfolio increased modestly to $158 million, resulting in a debt-to-equity ratio of 0.54x. Given its available credit capacity of an additional $115 million, subject to borrowing base limitations, Crystal has additional room to grow its portfolio without requiring an additional equity investment. We believe this investment offers a highly attractive risk return profile given the senior secured nature of Crystal's underlying loans. During Q1, our investment in Crystal paid Solar Capital a cash dividend of $7.7 million or an 11.2% annualized yield, which has been included in our net investment income for Q1. Crystal's asset-backed loans tend to have a shorter duration and greater amortization than does the loans in Solar's other portfolio. Given the shorter average life of these loans and more rapid amortization, we expect the size of the Crystal portfolio and the cash dividend distributed from Crystal to vary from quarter-to-quarter. Lastly, DS Waters continues to perform well. The integration of Standard Coffee, an acquisition made 1 year ago, is complete. And the cost efficiencies, as anticipated by management, have been realized in line with expectations. DS Waters' strong customer growth continues to drive an increase in organic revenues and the EBITDA performance over the prior year. On the origination front, during Q1, we invested $75 million across 3 portfolio companies. Our principal repayments and sales totaled approximately $69 million during this period. Let me highlight some of our first quarter investments. During Q1, we funded a $37 million first lien investment in Quantum Foods, which is a leading processor and distributor of ready-to-cook beef, pork and other poultry items. The all-in yield on this first lien floating-rate investment exceeds 11%, with leverage of approximately 3.5x at closing. Additionally, we invested approximately $20 million in the second lien term loan for TravelClick, which is a leading provider of resolution solutions, business intelligence and marketing solutions to the hospitality industry, particularly for the independent hotels that are trying to compete effectively with the larger chains. It's majority owned by Genstar Capital. The loan carries a yield in excess of 10%. During the first quarter, we received full repayments on 2 investments at a premium to our cost. First off, our $36 million investment in the mezzanine notes of CIBT Solutions was repaid at a premium to par. As you may recall, Solar Capital invested in CIBT, the leading global provider of expedited travel document processing services, back in December 2011 as part of ABRY Partners' buyout of the company. Our IRR to realization on this investment exceeded 20%. Finally, we were also repaid at a premium to par on our $17 million second lien investment in Asurion, as part of a comprehensive $4 billion refinancing of the company's first and second lien loans. Solar's IRR to realization on this investment was 11.5%. We continue to have a $13 million investment in the Asurion Holdco notes, which carries a coupon exceeding 11%. Now I'd like to turn the call back over to Michael.